Bank of America’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-820,600
| Closed | -$81.5M | – | 7769 |
|
|
2019
Q3 | $81.5M | Sell |
820,600
-133,200
| -14% | -$12.7M | 0.01% | 853 |
|
|
2019
Q2 | $88.2M | Sell |
953,800
-1,419,700
| -60% | -$135M | 0.01% | 791 |
|
|
2019
Q1 | $224M | Sell |
2,373,500
-983,400
| -29% | -$86M | 0.03% | 435 |
|
|
2018
Q4 | $215M | Buy |
3,356,900
+854,900
| +34% | +$63.1M | 0.04% | 412 |
|
|
2018
Q3 | $224M | Buy |
2,502,000
+1,678,500
| +204% | +$148M | 0.03% | 429 |
|
|
2018
Q2 | $65.4M | Buy |
823,500
+50,300
| +7% | +$4.18M | 0.01% | 920 |
|
|
2018
Q1 | $69M | Sell |
773,200
-395,600
| -34% | -$38M | 0.01% | 873 |
|
|
2017
Q4 | $122M | Buy |
1,168,800
+292,900
| +33% | +$33M | 0.02% | 644 |
|
|
2017
Q3 | $128M | Sell |
875,900
-152,800
| -15% | -$20.8M | 0.02% | 649 |
|
|
2017
Q2 | $134M | Sell |
1,028,700
-132,600
| -11% | -$16.2M | 0.03% | 573 |
|
|
2017
Q1 | $145M | Buy |
1,161,300
+278,300
| +32% | +$33.3M | 0.03% | 540 |
|
|
2016
Q4 | $102M | Buy |
883,000
+3,500
| +0.4% | +$390K | 0.02% | 658 |
|
|
2016
Q3 | $91.9M | Buy |
879,500
+135,900
| +18% | +$14.7M | 0.02% | 674 |
|
|
2016
Q2 | $73.3M | Sell |
743,600
-397,400
| -35% | -$41.1M | 0.02% | 774 |
|
|
2016
Q1 | $114M | Buy |
1,141,000
+307,800
| +37% | +$31.7M | 0.03% | 550 |
|
|
2015
Q4 | $99.8M | Buy |
833,200
+21,300
| +3% | +$2.46M | 0.02% | 653 |
|
|
2015
Q3 | $87.8M | Sell |
811,900
-267,700
| -25% | -$33.2M | 0.02% | 689 |
|
|
2015
Q2 | $125M | Buy |
1,079,600
+351,500
| +48% | +$40.2M | 0.04% | 463 |
|
|
2015
Q1 | $83.9M | Sell |
728,100
-1,048,200
| -59% | -$125M | 0.03% | 585 |
|
|
2014
Q4 | $199M | Buy |
1,776,300
+416,500
| +31% | +$43.9M | 0.07% | 312 |
|
|
2014
Q3 | $129M | Buy |
1,359,800
+124,300
| +10% | +$11.2M | 0.04% | 448 |
|
|
2014
Q2 | $106M | Buy |
1,235,500
+1,090,700
| +753% | +$82.9M | 0.03% | 525 |
|
|
2014
Q1 | $10.1M | Buy |
144,800
+35,400
| +32% | +$2.8M | ﹤0.01% | 1773 |
|
|
2013
Q4 | $9.24M | Buy |
109,400
+800
| +0.7% | +$63.3K | ﹤0.01% | 1926 |
|
|
2013
Q3 | $8.37M | Buy |
108,600
+34,400
| +46% | +$2.41M | ﹤0.01% | 1941 |
|
|
2013
Q2 | $4.34M | Buy |
+74,200
| New | +$4.47M | ﹤0.01% | 2417 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Bank of America's CELG Position: Q4 2019 in Review
Bank of America sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,074,972 shares — an estimated $405M sold.
Bank of America first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.88B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bank of America reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 4,074,972 Celgene Corp shares in Q4 2019, an estimated $405M.
- Bank of America first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Bank of America's Celgene Corp position peaked at $1.88B in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.